middle.news
Clarity Pharmaceuticals Posts $55.6M Half-Year Loss, Winds Up European Arm
10:12am on Friday 27th of February, 2026 AEDT
•
Healthcare
Read Story
Clarity Pharmaceuticals Posts $55.6M Half-Year Loss, Winds Up European Arm
10:12am on Friday 27th of February, 2026 AEDT
Key Points
Loss after tax surged 136% to $55.6 million
Revenue remained flat at zero
European subsidiary Clarity Pharmaceuticals Europe SA wound up
Net tangible assets per share rose to 62.6 cents
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
CLARITY PHARMACEUTICALS (ASX:CU6)
OPEN ARTICLE